Wipfli Financial Advisors LLC Acquires Shares of 709 Merit Medical Systems, Inc. (NASDAQ:MMSI)

Wipfli Financial Advisors LLC acquired a new stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 709 shares of the medical instruments supplier’s stock, valued at approximately $40,000.

A number of other institutional investors have also recently made changes to their positions in the business. Fort Washington Investment Advisors Inc. OH bought a new position in shares of Merit Medical Systems in the 3rd quarter valued at about $12,592,000. Emerald Advisers LLC lifted its holdings in shares of Merit Medical Systems by 1.4% in the 3rd quarter. Emerald Advisers LLC now owns 532,314 shares of the medical instruments supplier’s stock valued at $30,081,000 after acquiring an additional 7,106 shares during the last quarter. Ziegler Capital Management LLC lifted its holdings in shares of Merit Medical Systems by 0.9% in the 3rd quarter. Ziegler Capital Management LLC now owns 201,908 shares of the medical instruments supplier’s stock valued at $11,410,000 after acquiring an additional 1,816 shares during the last quarter. Texas Permanent School Fund lifted its holdings in shares of Merit Medical Systems by 10.7% in the 3rd quarter. Texas Permanent School Fund now owns 40,825 shares of the medical instruments supplier’s stock valued at $2,307,000 after acquiring an additional 3,954 shares during the last quarter. Finally, State of Alaska Department of Revenue lifted its holdings in shares of Merit Medical Systems by 1.9% in the 3rd quarter. State of Alaska Department of Revenue now owns 39,321 shares of the medical instruments supplier’s stock valued at $2,222,000 after acquiring an additional 731 shares during the last quarter. Institutional investors own 95.38% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on the stock. Piper Sandler increased their price target on shares of Merit Medical Systems from $70.00 to $73.00 in a report on Thursday, October 27th. Raymond James raised their price objective on shares of Merit Medical Systems from $71.00 to $72.00 and gave the stock an “outperform” rating in a research note on Thursday, October 27th. Canaccord Genuity Group downgraded shares of Merit Medical Systems from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $73.00 to $72.00 in a research note on Tuesday, December 20th. Canaccord Genuity Group raised their price objective on shares of Merit Medical Systems from $69.00 to $73.00 in a research note on Monday, November 7th. Finally, StockNews.com raised shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, January 3rd. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Merit Medical Systems currently has an average rating of “Buy” and a consensus target price of $73.50.

Merit Medical Systems Stock Performance

Shares of NASDAQ:MMSI opened at $69.97 on Wednesday. The firm has a market cap of $3.98 billion, a PE ratio of 64.79, a price-to-earnings-growth ratio of 2.26 and a beta of 1.01. The firm’s 50 day simple moving average is $70.70 and its 200-day simple moving average is $62.88. Merit Medical Systems, Inc. has a one year low of $50.46 and a one year high of $76.14. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.19 and a current ratio of 2.35.

Merit Medical Systems (NASDAQ:MMSI – Get Rating) last issued its earnings results on Wednesday, October 26th. The medical instruments supplier reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.53 by $0.11. The business had revenue of $287.18 million for the quarter, compared to analyst estimates of $273.03 million. Merit Medical Systems had a net margin of 5.43% and a return on equity of 14.14%. As a group, equities analysts predict that Merit Medical Systems, Inc. will post 2.57 EPS for the current year.

Merit Medical Systems Company Profile

(Get Rating)

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.